M
$ Value
$0
Shares
3,874
Price
$0
Filed
Apr 21
Insider
Name
Duarte Ira
Title
EVP, Chief Financial Officer
CIK
0001488864
Roles
Officer
Transaction Details
Transaction Date
2026-04-19
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
27,120
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock. | Includes 16,646 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2025. | The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).
Filing Info
Duarte Ira's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-19 | HRTX | M | — |
| 2026-04-19 | HRTX | M | $0 |
| 2026-01-19 | HRTX | M | — |
| 2026-01-19 | HRTX | M | $0 |
| 2025-10-31 | HRTX | M | — |
| 2025-10-31 | HRTX | M | $0 |
| 2025-10-19 | HRTX | M | — |
| 2025-10-19 | HRTX | M | $0 |
| 2025-07-31 | HRTX | M | — |
| 2025-07-31 | HRTX | M | $0 |
Other Insiders at HRTX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Forbes William P
EVP, Chief Development Officer
|
— | — | 2026-04-19 |
|
Collard Craig A
Chief Executive Officer
|
— | — | 2026-04-19 |
|
Duarte Ira
EVP, Chief Financial Officer
|
— | — | 2026-04-19 |